You are in: eMedicine Specialties > Neurology > Pediatric Neurology
|
Early Myoclonic Encephalopathy Last Updated: January 9, 2007 |
|
| Synonyms and related keywords: astatic myoclonic epilepsy of Doose, benign infantile myoclonic epilepsy, infantile spasms, progressive myoclonic epilepsy, severe infantile myoclonic epilepsy
|
|   |
AUTHOR INFORMATION
| Section 1 of 9  |
|
| Author: Raj D Sheth, MD, Professor, Departments of Neurology and Pediatrics, Director of Comprehensive Epilepsy Program, Department of Neurology, University of Wisconsin at Madison Coauthor(s): Shanker Dixit |
| Raj D Sheth, MD, is a member of the following medical societies:
American Academy of Neurology,
American Academy of Pediatrics,
American Epilepsy Society,
American Neurological Association, and
Child Neurology Society |
| Editor(s): James J Riviello, Jr, MD, Professor, Department of Neurology, Director of Epilepsy Program, Division of Epilepsy and Clinical Neurophysiology, Children's Hospital, Harvard University Medical School; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine;
Kenneth J Mack, MD, PhD, Visiting Associate Professor, Department of Neurology, University of Wisconsin at Madison; Associate Professor and Consultant, Department of Neurology, Division of Child and Adolescent Neurology, Mayo Medical School;
Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital;
and Nicholas Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants |
Disclosure
|   |
INTRODUCTION
| Section 2 of 9  |
|
Background: Myoclonic seizures can occur in many types of epilepsy; but in infancy and early childhood, they may occur as the dominant seizure type. The outlook and treatment of this condition differ from those of the more severe Lennox-Gastaut syndrome, which also may have myoclonic seizures as an important component. At times in this heterogenous group, nonmyoclonic seizures may dominate the clinical picture. Pathophysiology: Myoclonic seizures are produced via a cortical or a subcortical generator that utilizes a polysynaptic mechanism acting on muscles rather than a monosynaptic corticospinal pathway. Frequency:
- In the US: The incidence is approximately 1 case in 40,000 children.
Mortality/Morbidity: Typically, patients do not die of myoclonic seizures but of the pathophysiological condition underlying the myoclonic epilepsy. Aspiration pneumonia is common in this population and results in frequent hospitalization.
Race: Myoclonic seizures are reported in all races.
Sex: No sex preponderance is observed in myoclonic seizures.
Age: Typically, the onset of these disorders is during the first 3 years of life.
|   |
CLINICAL
| Section 3 of 9  |
|
History: Syndromes of myoclonic epilepsy may be divided into the following: - Symptomatic myoclonic epilepsy
- This is less frequent than the idiopathic (ie, cryptogenic) variety, and the age of onset is usually between a few months and 2-3 years. Clinical features include psychomotor retardation, and neuroimaging frequently demonstrates brain atrophy.
- Myoclonic jerks can occur alone, but they more commonly are associated with generalized clonic seizures. Rhythmic jerks can occur during sleep, with associated dystonic posturing during wakefulness.
- The prognosis for meaningful cognitive function is poor, although the myoclonic jerks may be controlled medically.
- Cryptogenic myoclonic epilepsy
- This group includes all patients with idiopathic seizures who display primarily recurrent myoclonic attacks. Some patients have infrequent generalized tonic-clonic seizures. Most myoclonic seizures are axial, which sometimes results in falls.
- The outcome in these patients is usually favorable, although about half the patients may have behavioral or cognitive dysfunction. This has sometimes been termed "benign myoclonic epilepsy."
- Myoclonic epilepsy with other types of brief, recurrent seizures
- In this group, all patients have myoclonic seizures associated with recurrent brief attacks of varying types.
- Examples of these attacks include atonic seizures, atypical absence, partial seizures, and brief tonic seizures.
- This is sometimes termed the myoclonic variant of Lennox-Gastaut syndrome.
- The outcome is worse than in the cryptogenic myoclonic epilepsy group; more patients have cognitive dysfunction, and a significant proportion of those have severe mental retardation. However, the outcome is better than in patients with Lennox-Gastaut syndrome.
- Myoclonic epilepsy associated with clonic seizures and multiple seizure types
- This condition is sometimes termed "severe myoclonic epilepsy" and occurs in a significant proportion of severe childhood epilepsies. The age of onset of seizures is between 4 and 11 months, and the seizures are initially unilateral or generalized clonic movements (or rarely, generalized tonic-clonic movements).
- Seizures are usually long lasting, from 10-90 minutes in duration, and mostly associated with fever or minor infections.
- Myoclonic seizures appear by the second or third year and are often photosensitive.
- Atypical absence seizures may be seen without an electrographic correlate.
- Initially, development may be normal; later, cognitive delays become evident and are usually moderate to severe. Most patients have fluctuating ataxia and erratic myoclonus.
- The myoclonic seizures may resolve after a few years, but other seizures tend to be persistent. Nonconvulsive status is common.
- EEG findings are normal initially, despite frequent seizures.
- Later, generalized bursts of spike-wave and polyspike-wave complexes are seen.
- Multifocal spikes also may be seen and may be unilateral.
- Most patients are photosensitive and this feature may be diagnostic if present in children younger than 1 year.
- MRI and CT scans are usually normal and do not show focal lesions or atrophy. Generally, the outlook is poor; most children are markedly dependent on care or institutionalized.
- Neonatal myoclonic epilepsy
- This syndrome presents in the first 4 weeks of life with prominent myoclonic seizures.
- The seizures usually result from a severe metabolic disorder, including that associated with elevated glycine levels in the cerebrospinal fluid (CSF), although they may be associated with any condition that produces severe brain dysfunction.
- Distinguishing neonatal myoclonic epilepsy from benign neonatal sleep myoclonus is important. The latter condition is seen in healthy infants and occurs only in sleep.
- EEG is very helpful in distinguishing between these 2 conditions. In benign sleep myoclonus, EEG findings are normal even when the infant is having myoclonus. In neonatal myoclonic epilepsy, EEG findings are always markedly abnormal in background and may even show a burst-suppression pattern.
Physical: - Abrupt and brief myoclonic jerks occur several times a day. They can manifest as head nodding, abrupt abduction of arms, or sudden falls.
- Eyelid or facial muscles are affected commonly, although axial myoclonic jerks are most common and occur in 90% of patients.
- Myoclonic seizures commonly occur on awakening, and some may be precipitated by photic stimuli. Rarely, myoclonic seizures occur continuously as myoclonic status epilepticus with partial preservation of consciousness.
- Although myoclonic seizures may occur as the sole type of seizures in some patients, they more commonly are associated with other seizures.
- Generalized tonic-clonic seizures are the most common associated type. Brief generalized clonic seizures or unilateral clonic seizures also may be seen.
- Atypical absence seizures occur in 40%, and pure atonic seizures may also occur.
- Pure tonic seizures are not seen (this is an important distinguishing feature from Lennox-Gastaut syndrome).
- During the physical examination, particular attention should be given to conditions that may mimic myoclonic seizures. In the case of isolated myoclonic jerks, tics or mannerisms may be identified mistakenly as myoclonic attacks; usually, however, the diagnosis becomes clear over time.
- At times, absence seizures may be associated with myoclonic or clonic attacks. EEG is useful in differentiating myoclonic attacks from absence seizures.
- Progressive neurodegenerative diseases frequently present with myoclonic activity and other seizures types.
- Neuronal ceroid lipofuscinosis (NCL) is important to consider in patients aged 2-5 years.
- EEG is useful in NCL, since photic stimulation at 1 Hz produces giant evoked potentials in the form of a spike followed by a slow wave.
- Patients with Lennox-Gastaut syndrome have a mixed seizure disorder, including tonic seizures and drop attacks; however, myoclonic attacks are not a prominent feature. Additionally, EEG in Lennox-Gastaut syndrome has a more uniform slow spike and wave discharge pattern.
- Some severe cases of myoclonic epilepsy may be confused with febrile seizures. Prolonged duration, rapid recurrence, and occurrence of afebrile seizures differentiates myoclonic epilepsy from febrile seizures.
Causes: - Inborn errors of metabolism
- Cryptogenic causes: Children with this condition have no identifiable cause for their syndrome and an appropriate workup for the seizures is negative.
|   |
DIFFERENTIALS
| Section 4 of 9  |
|
Abnormal Neonatal EEG Absence Seizures Ambulatory Electroencephalography (EEG) Benign Childhood Epilepsy Benign Neonatal Convulsions Cerebral Palsy Cocaine Complex Partial Seizures Disorders of Carbohydrate Metabolism
EEG Seizure Monitoring EEG in Common Epilepsy Syndromes Early Myoclonic Encephalopathy Epilepsy in Children with Mental Retardation Epileptiform Discharges Febrile Seizures First Seizure: Pediatric Perspective Haemophilus Meningitis Herpes Simplex Encephalitis
Hydrocephalus Infantile Spasm (West Syndrome) Inherited Metabolic Disorders Intracranial Hemorrhage Landau-Kleffner Syndrome Menkes Disease
|
|
Patient Education
|
|
Click here for patient education.
|
|
|
|
|
|   |
WORKUP
| Section 5 of 9  |
|
Imaging Studies:
- Brain MRI is usually normal, although congenital brain abnormalities sometimes are observed.
- Computed tomography (CT) scan is usually normal. MRI is preferred to CT scan.
Other Tests:
- The ictal EEG correlate of myoclonic seizures consists of fast spike-wave discharges (>2.5 Hz), which at times are associated with slower 2- to 2.5-Hz discharges. Interictal recordings may be normal or show slowing, depending on the etiology.
- Brief (<3 seconds) interictal bursts of irregular polyspike-waves may be seen either spontaneously or with photic stimulation. The occurrence of these discharges is increased during non-rapid eye movement (REM) sleep.
- Atypical absence seizures are associated with brief bursts of fast spike-wave activity. During atonic attacks, the EEG shows an irregular burst of arrhythmic fast spike and wave complexes, which are bilateral and symmetrical.
Procedures:
- Lumbar puncture can help to rule out neurodegenerative diseases. CSF findings suggestive of neurodegenerative disease include an elevated protein with an unremarkable or mildly elevated WBC count.
|   |
TREATMENT
| Section 6 of 9  |
|
Medical Care: - The mainstay of medical therapy for myoclonic epilepsy is sodium valproate, ethosuximide, or benzodiazepines.
- Patients with the benign form respond well to valproate or ethosuximide.
- Either one of the drugs may be started; if both fail independently, they may be combined.
- The duration of treatment is tailored on an individual basis but is usually approximately 5 years.
- Second-line medications include clonazepam, methsuximide, acetazolamide, and sulthiame.
- Treatment for the more severe myoclonic epilepsies is more difficult and is essentially the same as for Lennox-Gastaut syndrome.
- All types of antiepileptic medications may be tried, with the exception of vigabatrin and carbamazepine, which actually may worsen the seizures.
- Combination therapy with valproate and benzodiazepines may be the best alternative.
- Adrenocorticotropic hormone (ACTH), steroids, and immunoglobulins have been tried but have shown no significant benefit.
Consultations: Patients should be evaluated by a pediatric neurologist. If dysmorphic features are present, a genetic evaluation may be useful. Diet: The ketogenic diet may be useful in caring for children with particularly refractory epilepsy. This should be instituted only on an inpatient basis, paying particular attention to the possibility of dehydration. Activity: Caution should be used in children with drop attacks, as they may fall and injure themselves. A helmet can be protective. Routine seizure precautions are also applicable.
|   |
MEDICATION
| Section 7 of 9  |
|
The goals of pharmacotherapy are to reduce morbidity and prevent complications.
Drug Category: Antiepileptic agents -- Patients with the benign form respond very well to valproate or ethosuximide. Drug Name
| Valproic acid (Depakote) -- Chemically unrelated to other drugs that treat seizure disorders. Although mechanism of action not established, activity may be related to increased brain levels of GABA, or enhanced GABA action. Valproate also may potentiate postsynaptic GABA responses, affect potassium channels, or have direct membrane-stabilizing effect.
Use in young children (younger than 2 years) associated with risk of hepatotoxicity. This risk estimated to occur in fewer than 1 in 250 children treated.| Adult Dose | Initial: 5-15 mg/kg/d PO
Maintenance: 15-25 mg/kg/d PO| Pediatric Dose | Initial: 10-30 mg/kg/d PO
Maintenance: 30 mg/kg/d PO| Contraindications | Documented hypersensitivity; hepatic disease/dysfunction |
|---|
| Interactions | Cimetidine, salicylates, felbamate, and erythromycin may increase toxicity; rifampin may reduce levels significantly; in children, salicylates cause decreases in protein binding and metabolism of valproate; may result in variable changes of carbamazepine concentrations with possible loss of seizure control; may increase diazepam and ethosuximide toxicity (monitor closely); may increase phenobarbital and phenytoin levels while either may decrease valproate levels; may displace warfarin from protein-binding sites (monitor coagulation tests); may increase zidovudine levels in HIV-seropositive patients |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Thrombocytopenia and abnormal coagulation parameters have occurred; risk of thrombocytopenia increases significantly at total trough valproate plasma concentrations >110 mcg/mL in females and >135 mcg/mL in males; at periodic intervals and prior to surgery, determine platelet count and bleeding time before initiating therapy; reduce dose or discontinue therapy if hemorrhage, bruising, or hemostasis/coagulation disorder occur; hyperammonemia may occur; monitor patients closely for appearance of malaise, weakness, facial edema, anorexia, jaundice, and vomiting |
|---|
|
|---|
|
|---|
|
|---|
Drug Name
| Ethosuximide (Zarontin) -- Mechanism of action based on reducing current in T-type calcium channels found on thalamic neurons. Spike-and-wave pattern during petit mal seizures thought to be initiated in thalamocortical relays by activation of these channels. Used as adjunctive medication to valproic acid if that medication has failed to control seizures. |
|---|
| Adult Dose | 500-2000 g/d PO |
|---|
| Pediatric Dose | 15-40 mg/kg/d PO |
|---|
| Contraindications | Documented hypersensitivity; blood dyscrasias; renal or hepatic disease |
|---|
| Interactions | Phenytoin, carbamazepine, primidone, and phenobarbital may decrease effects; isoniazid may inhibit hepatic metabolism, increasing toxicity |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Blood dyscrasias, which may be fatal, may occur (monitor CBC); caution in hepatic or renal disease; abrupt withdrawal may precipitate absence status |
|---|
Drug Name
| Clonazepam (Klonopin) -- Suppresses muscle contractions by facilitating inhibitory GABA neurotransmission and other inhibitory transmitters. Useful in immediate control of seizures, although often associated with relatively rapid loss of efficacy against seizures. |
|---|
| Adult Dose | 0.05-0.2 mg/kg/d PO |
|---|
| Pediatric Dose | Administer as in adults |
|---|
| Contraindications | Documented hypersensitivity; severe liver disease; acute narrow-angle glaucoma |
|---|
| Interactions | Phenytoin and barbiturates may reduce effects; CNS depressants increase toxicity |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Caution in chronic respiratory disease or impaired renal function; withdrawal symptoms can result from abrupt discontinuation of medication |
|---|
|   |
FOLLOW-UP
| Section 8 of 9  |
|
Further Outpatient Care:
- Serial EEGs often are required to ensure that patients are responding to treatment and that subclinical seizures are not occurring.
- Typical EEG findings in responsive patients include the disappearance of polyspike and wave activity and other associated epileptiform discharges.
Prognosis:
- Prognosis depends on the underlying etiology and the syndrome type.
- Patients with a benign syndrome typically respond well to medication. These patients usually have a good prognosis and often outgrow the epilepsy.
- In symptomatic myoclonic epilepsy syndromes, the prognosis is usually less favorable with regard to seizure control and developmental progress.
|   |
BIBLIOGRAPHY
| Section 9 of 9 |
|
-
Aicardi J: Myoclonic epilepsies of infancy and childhood. Adv Neurol 1986; 43: 11-31[Medline].
-
Doose H, Lunau H, Castiglione E, Waltz S: Severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics 1998 Oct; 29(5): 229-38[Medline].
-
Lombroso CT: Early myoclonic encephalopathy, early infantile epileptic encephalopathy, and benign and severe infantile myoclonic epilepsies: a critical review and personal contributions. J Clin Neurophysiol 1990 Jul; 7(3): 380-408[Medline].
-
Shahwan A, Farrell M, Delanty N: Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 2005 Apr; 4(4): 239-48[Medline].
-
Sheth RD: Electroencephalogram in developmental delay: specific electroclinical syndromes. Semin Pediatr Neurol 1998 Mar; 5(1): 45-51[Medline].
-
Wallace SJ: Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res 1998 Jan; 29(2): 147-54[Medline].
Early Myoclonic Encephalopathy excerpt |